Clinical Trial Update: MOTS-c for Improving Insulin Sensitivity in Adults With Prediabetes and Overweight/Obesity [Phase 2]

View source ↗

Summary

Phase 2 clinical trial assessing MOTS-c to improve insulin sensitivity in adults with prediabetes and overweight/obesity is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Insulin Resistance
• Obesity
• Prediabetes

Drugs mentioned

• MOTS-c (MOTS-c)

Snippet

Sponsor: Hudson Biotech | Conditions: Prediabetes, Insulin Resistance | Phase 2 | Status: RECRUITING